JP2005511632A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005511632A5 JP2005511632A5 JP2003545300A JP2003545300A JP2005511632A5 JP 2005511632 A5 JP2005511632 A5 JP 2005511632A5 JP 2003545300 A JP2003545300 A JP 2003545300A JP 2003545300 A JP2003545300 A JP 2003545300A JP 2005511632 A5 JP2005511632 A5 JP 2005511632A5
- Authority
- JP
- Japan
- Prior art keywords
- receptor agonist
- cannabinoid receptor
- medicament
- acceptable salt
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0103936 | 2001-11-23 | ||
| PCT/SE2002/002108 WO2003043619A1 (en) | 2001-11-23 | 2002-11-20 | New use for the treatment of gastroesophageal reflux disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005511632A JP2005511632A (ja) | 2005-04-28 |
| JP2005511632A5 true JP2005511632A5 (https=) | 2006-01-12 |
Family
ID=20286096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003545300A Pending JP2005511632A (ja) | 2001-11-23 | 2002-11-20 | 胃食道逆流疾患の治療のための新しい使用 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7358245B2 (https=) |
| EP (1) | EP1453497A1 (https=) |
| JP (1) | JP2005511632A (https=) |
| KR (1) | KR20050044582A (https=) |
| CN (1) | CN1610542A (https=) |
| AR (1) | AR037299A1 (https=) |
| AU (1) | AU2002353700A1 (https=) |
| BR (1) | BR0214319A (https=) |
| CA (1) | CA2466916A1 (https=) |
| HU (1) | HUP0402080A3 (https=) |
| IL (1) | IL161748A0 (https=) |
| IS (1) | IS7272A (https=) |
| MX (1) | MXPA04004774A (https=) |
| NO (1) | NO20042613L (https=) |
| NZ (1) | NZ532844A (https=) |
| PL (1) | PL369402A1 (https=) |
| RU (1) | RU2280443C2 (https=) |
| TW (1) | TW200407110A (https=) |
| WO (1) | WO2003043619A1 (https=) |
| ZA (1) | ZA200403785B (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005039550A2 (en) * | 2003-10-24 | 2005-05-06 | Solvay Pharmaceuticals Gmbh | Novel medical uses of compounds showing cb1-antagonistic activity and combination treatment involving said compounds |
| WO2005060971A1 (en) * | 2003-12-18 | 2005-07-07 | Astrazeneca Ab | Treatment of reflux-related diseases |
| SE0303490D0 (sv) * | 2003-12-19 | 2003-12-19 | Astrazeneca Ab | New use V |
| AU2005298692A1 (en) | 2004-10-25 | 2006-05-04 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type I, obesity and related conditions |
| US8628796B2 (en) * | 2004-12-09 | 2014-01-14 | Insys Therapeutics, Inc. | Room-temperature stable dronabinol formulations |
| WO2008019146A2 (en) * | 2006-08-04 | 2008-02-14 | Insys Therapeutics Inc. | Aqueous dronabinol formulations |
| CA2698752A1 (en) * | 2007-08-06 | 2009-02-12 | Insys Therapeutics Inc. | Oral cannabinoid liquid formulations and methods of treatment |
| EP2205240A1 (en) * | 2007-10-02 | 2010-07-14 | Ariel-University Research And Development Company, Ltd. | Endocannabinoids for enhancing growth and development in infants |
| US20090208588A1 (en) * | 2008-02-19 | 2009-08-20 | Roger Wayne Brown | GERD carbohydrate compositions |
| CN103588672A (zh) * | 2013-10-28 | 2014-02-19 | 史克勇 | 一种治疗癌性疼痛的药物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2735774B1 (fr) * | 1995-06-21 | 1997-09-12 | Sanofi Sa | Utilisation de composes agonistes du recepteur cb2 humain pour la preparation de medicaments immunomodulateurs, nouveaux composes agonistes du recepteur cb2 et les compositions pharmaceutiques les contenant |
| EP0887340A4 (en) * | 1996-02-06 | 2000-03-29 | Japan Tobacco Inc | CHEMICAL COMPOUNDS AND THEIR PHARMACEUTICAL USE |
| US5939429A (en) * | 1997-09-30 | 1999-08-17 | Virginia Commonwealth University | Cardiovascular uses of cannabinoid compounds |
| WO1999057106A1 (en) * | 1998-05-04 | 1999-11-11 | The University Of Connecticut | Novel analgesic and immunomodulatory cannabinoids |
| CA2330681C (en) | 1998-05-29 | 2008-08-26 | Andrea Giuffrida | Control of pain with endogenous cannabinoids |
| GB9923738D0 (en) * | 1999-10-07 | 1999-12-08 | Nestle Sa | Nutritional composition |
| IL132661A (en) | 1999-10-31 | 2008-11-26 | Raphael Mechoulam | Agonists specific for peripheral cannabinoid receptors |
| SE9904507D0 (sv) | 1999-12-09 | 1999-12-09 | Astra Ab | New compounds |
| AU6690001A (en) * | 2000-06-15 | 2001-12-24 | Schering Corp | Thrombin receptor antagonists |
| AUPR118000A0 (en) * | 2000-11-02 | 2000-11-23 | Amrad Operations Pty. Limited | Therapeutic molecules and methods |
| FR2816938B1 (fr) * | 2000-11-22 | 2003-01-03 | Sanofi Synthelabo | Derives de 3-aroylindole, leur procede de preparation et les compositions pharmaceutiques en contenant |
| US20020077322A1 (en) | 2000-12-15 | 2002-06-20 | Ayoub George S. | Protection of neurons against glutamate-induced damage in glaucoma and other conditions |
-
2002
- 2002-11-07 TW TW091132760A patent/TW200407110A/zh unknown
- 2002-11-11 AR ARP020104319A patent/AR037299A1/es not_active Application Discontinuation
- 2002-11-20 KR KR1020047007819A patent/KR20050044582A/ko not_active Withdrawn
- 2002-11-20 BR BR0214319-4A patent/BR0214319A/pt not_active IP Right Cessation
- 2002-11-20 EP EP02789069A patent/EP1453497A1/en not_active Withdrawn
- 2002-11-20 WO PCT/SE2002/002108 patent/WO2003043619A1/en not_active Ceased
- 2002-11-20 IL IL16174802A patent/IL161748A0/xx unknown
- 2002-11-20 CA CA002466916A patent/CA2466916A1/en not_active Abandoned
- 2002-11-20 NZ NZ532844A patent/NZ532844A/en unknown
- 2002-11-20 MX MXPA04004774A patent/MXPA04004774A/es not_active Application Discontinuation
- 2002-11-20 RU RU2004114843/15A patent/RU2280443C2/ru not_active IP Right Cessation
- 2002-11-20 JP JP2003545300A patent/JP2005511632A/ja active Pending
- 2002-11-20 CN CNA028233514A patent/CN1610542A/zh active Pending
- 2002-11-20 PL PL02369402A patent/PL369402A1/xx unknown
- 2002-11-20 AU AU2002353700A patent/AU2002353700A1/en not_active Abandoned
- 2002-11-20 US US10/496,431 patent/US7358245B2/en not_active Expired - Fee Related
- 2002-11-20 HU HU0402080A patent/HUP0402080A3/hu unknown
-
2004
- 2004-05-17 ZA ZA200403785A patent/ZA200403785B/en unknown
- 2004-05-19 IS IS7272A patent/IS7272A/is unknown
- 2004-06-22 NO NO20042613A patent/NO20042613L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109549927A (zh) | 固溶体组合物及其在心血管疾病中的用途 | |
| CN100430056C (zh) | Mglur5拮抗剂在制备治疗gerd的药物中的用途 | |
| US20110237563A1 (en) | Fast dissolving drug delivery systems | |
| JP5712452B2 (ja) | 診断された呼吸疾患を有する患者もしくは診断未確定の呼吸疾患を有する患者におけるオピオイド鎮痛薬の投与に関連する危険性を減少するための方法および組成 | |
| WO2012092594A2 (en) | Preparations for topical prevention and/or treatment of oral allergic symptoms due to oral contact with fruits and/or vegetables | |
| WO2007070504A2 (en) | Stable and palatable oral liquid sumatriptan compositions | |
| JP2005511632A5 (https=) | ||
| TW201912153A (zh) | 用於治療ｂ型肝炎的化合物、醫藥組合物及方法 | |
| CN101939001B (zh) | 用于治疗卵巢癌的含有紫杉醇的组合 | |
| EP4297868A1 (en) | Use of aprepitant for treating alzheimer's disease | |
| JP2007512273A (ja) | ベータ−３−アドレノセプター作用薬及びプロスタグランジン代謝に影響を及ぼす活性物質から成る医薬組成物 | |
| US10682343B2 (en) | Snoring treatment | |
| JP2001520678A (ja) | 睡眠無呼吸症候群の治療に有効な医薬の製造への特異的５ｈｔ▲下２▼レセプター拮抗薬の使用 | |
| US20050101607A1 (en) | Pharmaceutical composition containing a beta-3-adrenoceptor agonist and an alpha antagonist and/or a 5-alpha reductase inhibitor | |
| RU2004114843A (ru) | Новое применение для лечения заболеваний гастроэзофагеальной рефлюксной болезни | |
| KR20020070525A (ko) | 디아미노트리플루오로메틸피리딘의 유도체를 함유하는소화기 질환 치료제 또는 예방제 | |
| CN107073015B (zh) | 用于治疗吸烟者中的非小细胞肺癌的维利帕尼与卡铂和紫杉醇的组合 | |
| JP5042625B2 (ja) | 抗炎症剤として有用なα−アミノアミド誘導体 | |
| CA2464309A1 (en) | Combinations comprising a selective cyclooxygenase-2 inhibitor | |
| US20050154041A1 (en) | Pharmaceutical composition consisting of a beta-3-adrenoceptor agonist and alpha-agonist | |
| AU2007325972A1 (en) | S-nitrosothiol compounds and related derivatives | |
| JP2016503035A (ja) | 肝疾患または肝障害の治療のための使用および方法 | |
| EP3965823B1 (en) | Use of gold nanoclusters in treating hypercholesterolemia or hypercholesterolemia-associated diseases | |
| CN102781437A (zh) | 阿戈美拉汀在得到预定治疗强迫性障碍(ocd)的药物中的用途 | |
| CN117379423A (zh) | 依达拉奉在自闭症谱系障碍治疗中的应用 |